294 related articles for article (PubMed ID: 18415808)
1. Long-term effects of budesonide on inflammatory status in COPD.
Boorsma M; Lutter R; van de Pol MA; Out TA; Jansen HM; Jonkers RE
COPD; 2008 Apr; 5(2):97-104. PubMed ID: 18415808
[TBL] [Abstract][Full Text] [Related]
2. Sputum eosinophilia and the short term response to inhaled mometasone in chronic obstructive pulmonary disease.
Brightling CE; McKenna S; Hargadon B; Birring S; Green R; Siva R; Berry M; Parker D; Monteiro W; Pavord ID; Bradding P
Thorax; 2005 Mar; 60(3):193-8. PubMed ID: 15741434
[TBL] [Abstract][Full Text] [Related]
3. The effect of inhaled corticosteroids on bronchoalveolar lavage cells and IL-8 levels in stable COPD patients.
Ozol D; Aysan T; Solak ZA; Mogulkoc N; Veral A; Sebik F
Respir Med; 2005 Dec; 99(12):1494-500. PubMed ID: 15946834
[TBL] [Abstract][Full Text] [Related]
4. Anti-inflammatory effects of combined budesonide/formoterol in COPD exacerbations.
Bathoorn E; Liesker JJ; Postma DS; Boorsma M; Bondesson E; Koëter GH; Kauffman HF; van Oosterhout AJ; Kerstjens HA
COPD; 2008 Oct; 5(5):282-90. PubMed ID: 18972276
[TBL] [Abstract][Full Text] [Related]
5. Long-term treatment with inhaled budesonide in persons with mild chronic obstructive pulmonary disease who continue smoking. European Respiratory Society Study on Chronic Obstructive Pulmonary Disease.
Pauwels RA; Löfdahl CG; Laitinen LA; Schouten JP; Postma DS; Pride NB; Ohlsson SV
N Engl J Med; 1999 Jun; 340(25):1948-53. PubMed ID: 10379018
[TBL] [Abstract][Full Text] [Related]
6. Fast onset of effect of budesonide/formoterol versus salmeterol/fluticasone and salbutamol in patients with chronic obstructive pulmonary disease and reversible airway obstruction.
Lindberg A; Szalai Z; Pullerits T; Radeczky E
Respirology; 2007 Sep; 12(5):732-9. PubMed ID: 17875063
[TBL] [Abstract][Full Text] [Related]
7. Stable COPD: predicting benefit from high-dose inhaled corticosteroid treatment.
Leigh R; Pizzichini MM; Morris MM; Maltais F; Hargreave FE; Pizzichini E
Eur Respir J; 2006 May; 27(5):964-71. PubMed ID: 16446316
[TBL] [Abstract][Full Text] [Related]
8. [The relationship between sputum eosinophils and responses to treatment of inhaled glucocorticoids in patients with persistent asthma].
Jiang YW; Sun YC; Zhou QT; Gai XY; Cao WL; Yao WZ
Zhonghua Jie He He Hu Xi Za Zhi; 2007 Jun; 30(6):447-51. PubMed ID: 17673020
[TBL] [Abstract][Full Text] [Related]
9. Inhaled corticosteroid effects both eosinophilic and non-eosinophilic inflammation in asthmatic patients.
Basyigit I; Yildiz F; Ozkara SK; Boyaci H; Ilgazli A
Mediators Inflamm; 2004 Aug; 13(4):285-91. PubMed ID: 15545060
[TBL] [Abstract][Full Text] [Related]
10. Safety and application of induced sputum analysis in childhood asthma.
Covar RA; Spahn JD; Martin RJ; Silkoff PE; Sundstrom DA; Murphy J; Szefler SJ
J Allergy Clin Immunol; 2004 Sep; 114(3):575-82. PubMed ID: 15356559
[TBL] [Abstract][Full Text] [Related]
11. Repeatability of inflammatory parameters in induced sputum of COPD patients.
Boorsma M; Lutter R; van de Pol MA; Out TA; Jansen HM; Jonkers RE
COPD; 2007 Dec; 4(4):321-9. PubMed ID: 18027159
[TBL] [Abstract][Full Text] [Related]
12. [Long-term effect of inhaled budesonide in patients with mild to moderate chronic obstructive lung disease. The Osterbro Study].
Vestbo J; Sørensen T; Lange P; Brix A; Torre P; Viskum K
Ugeskr Laeger; 2000 Jan; 162(4):493-7. PubMed ID: 10697447
[TBL] [Abstract][Full Text] [Related]
13. Bromotyrosines in sputum proteins and treatment effects of terbutaline and budesonide in asthma.
van Dalen CJ; Aldridge RE; Chan T; Senthilmohan R; Hancox RJ; Cowan JO; Taylor DR; Town GI; Kettle AJ
Ann Allergy Asthma Immunol; 2009 Oct; 103(4):348-53. PubMed ID: 19852201
[TBL] [Abstract][Full Text] [Related]
14. Increase in airway neutrophils after oral but not inhaled corticosteroid therapy in mild asthma.
Nguyen LT; Lim S; Oates T; Chung KF
Respir Med; 2005 Feb; 99(2):200-7. PubMed ID: 15715187
[TBL] [Abstract][Full Text] [Related]
15. New developments in the treatment of COPD: comparing the effects of inhaled corticosteroids and N-acetylcysteine.
van Overveld FJ; Demkow U; Górecka D; de Backer WA; Zielinski J
J Physiol Pharmacol; 2005 Sep; 56 Suppl 4():135-42. PubMed ID: 16204787
[TBL] [Abstract][Full Text] [Related]
16. Effects of montelukast compared to double dose budesonide on airway inflammation and asthma control.
Barnes N; Laviolette M; Allen D; Flood-Page P; Hargreave F; Corris P; O'Connor B; Tate H; Parker D; Pavord I
Respir Med; 2007 Aug; 101(8):1652-8. PubMed ID: 17481879
[TBL] [Abstract][Full Text] [Related]
17. Effect of cetirizine dihydrochloride on the airway response to hypertonic saline aerosol in patients with chronic obstructive pulmonary disease (COPD).
Grönke L; Schlenker J; Holz O; Out TA; Magnussen H; Jörres RA
Respir Med; 2005 Oct; 99(10):1241-8. PubMed ID: 16140224
[TBL] [Abstract][Full Text] [Related]
18. Mineral status of COPD patients under long-term inhaled corticosteroid therapy.
Buyukkaplan US; Akkaya A; Yildiz M; Bircan A; Aksoy Dogan A; Ozturk O
J Prosthodont; 2008 Aug; 17(6):462-7. PubMed ID: 18573148
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of acute bronchodilator reversibility in patients with symptoms of GOLD stage I COPD.
O'Donnell DE; Laveneziana P; Ora J; Webb KA; Lam YM; Ofir D
Thorax; 2009 Mar; 64(3):216-23. PubMed ID: 19052054
[TBL] [Abstract][Full Text] [Related]
20. Bronchodilator reversibility, airway eosinophilia and anti-inflammatory effects of inhaled fluticasone in COPD are not related.
Reid DW; Wen Y; Johns DP; Williams TJ; Ward C; Walters EH
Respirology; 2008 Nov; 13(6):799-809. PubMed ID: 18811878
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]